Mumbai:Under this agreement, Transasia will exclusively market kits for Infectious diseases like Pneumonia, Brucellosis, Dengue, Infectious Mononucleosis and many more. Customized products and services will be evaluated by both management teams to maximize benefits to the Indian patients.

Vircell is a microbiology company with global presence in the market. Its international focus can be seen in the worldwide presence of its products, in laboratories of more than 60 countries. All its activities are ISO certified and its Clinical Diagnostic reagents are CE marked.

Vircell’s scientific outlook and orientation on quality converges very well with Transasia’s single minded focus on customer satisfaction, right from product conception to after-sales service.

Both, Transasia and Vircell believe in developing innovative products, bringing significant advances to the IVD market. This new basket of wide spectrum Infectious Disease products from Transasia is definitely an added advantage which will benefit Indian customers due to high quality at affordable prices